Δεσλοραταδίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Δεσλοραταδίνη" in Greek language version.

refsWebsite

Global rank Greek rank

10nih.gov

4^th place

7doi.org

2^nd place

3^rd place

3europa.eu

68^th place

24^th place

3web.archive.org

1^st place

2worldcat.org

5^th place

8^th place

1books.google.com

3^rd place

6^th place

1aafp.org

1,916^th place

1,112^th place

1drugs.com

399^th place

130^th place

1fda.gov

447^th place

368^th place

1bmjjournals.com

low place

3,112^th place

aafp.org

See S (2003). «Desloratadine for allergic rhinitis». Am Fam Physician 68 (10): 2015–6. PMID 14655812. Αρχειοθετήθηκε από το πρωτότυπο στις 2005-07-24. https://web.archive.org/web/20050724082052/http://www.aafp.org/afp/20031115/steps.html. Ανακτήθηκε στις 2022-02-02.

bmjjournals.com

bmj.bmjjournals.com

«Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice». BMJ 320 (7243): 1184–6. 2000. doi:10.1136/bmj.320.7243.1184. PMID 10784544. PMC 27362. http://bmj.bmjjournals.com/cgi/content/full/320/7243/1184.

books.google.com

Fischer, Jnos· Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. σελ. 549. ISBN 9783527607495.

doi.org

dx.doi.org

Murdoch, David; Goa, Karen L.; Keam, Susan J. (April 7, 2003). «Desloratadine: an update of its efficacy in the management of allergic disorders». Drugs 63 (19): 2051–2077. doi:10.2165/00003495-200363190-00010. PMID 12962522.
«Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study». J Eur Acad Dermatol Venereol 28 (12): 1654–60. 2014. doi:10.1111/jdv.12403. PMID 25081735.
Layton AM (2016). «Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris». Dermatol Clin 34 (2): 147–57. doi:10.1016/j.det.2015.11.008. PMID 27015774.
González-Núñez, Vanesa; Valero, Antonio; Mullol, Joaquim (2013-04-11). «Safety evaluation of desloratadine in allergic rhinitis». Expert Opinion on Drug Safety (Informa Healthcare) 12 (3): 445–453. doi:10.1517/14740338.2013.788148. ISSN 1474-0338. PMID 23574541.
«Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence». World Allergy Organ J 4 (2): 47–53. 2011. doi:10.1097/WOX.0b013e3182093e19. PMID 23268457.
Kazmi, F.; Yerino, P.; Barbara, J. E.; Parkinson, A. (2015-07-01). «Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor». Drug Metabolism and Disposition 43 (9): 1294–1302. doi:10.1124/dmd.115.065011. ISSN 1521-009X. PMID 26135009.
«Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice». BMJ 320 (7243): 1184–6. 2000. doi:10.1136/bmj.320.7243.1184. PMID 10784544. PMC 27362. http://bmj.bmjjournals.com/cgi/content/full/320/7243/1184.

drugs.com

Drugs.com Desloratadine entry at drugs.com international Page accessed May 4, 2015

europa.eu

ema.europa.eu

«Allex EPAR». European Medicines Agency (EMA).
«Aerius: EPAR – Product Information» (PDF). European Medicines Agency. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 5 Ιουλίου 2019. Ανακτήθηκε στις 21 Ιανουαρίου 2022.
«Aerius: EPAR – Scientific Discussion» (PDF). European Medicines Agency. 3 Απριλίου 2006. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2018. Ανακτήθηκε στις 2 Φεβρουαρίου 2022.

fda.gov

accessdata.fda.gov

«Clarinex: Prescribing Information» (PDF). U.S. Food and Drug Administration. Ανακτήθηκε στις 21 Ιανουαρίου 2022.

nih.gov

ncbi.nlm.nih.gov

Murdoch, David; Goa, Karen L.; Keam, Susan J. (April 7, 2003). «Desloratadine: an update of its efficacy in the management of allergic disorders». Drugs 63 (19): 2051–2077. doi:10.2165/00003495-200363190-00010. PMID 12962522.
See S (2003). «Desloratadine for allergic rhinitis». Am Fam Physician 68 (10): 2015–6. PMID 14655812. Αρχειοθετήθηκε από το πρωτότυπο στις 2005-07-24. https://web.archive.org/web/20050724082052/http://www.aafp.org/afp/20031115/steps.html. Ανακτήθηκε στις 2022-02-02.
«Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study». J Eur Acad Dermatol Venereol 28 (12): 1654–60. 2014. doi:10.1111/jdv.12403. PMID 25081735.
Layton AM (2016). «Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris». Dermatol Clin 34 (2): 147–57. doi:10.1016/j.det.2015.11.008. PMID 27015774.
González-Núñez, Vanesa; Valero, Antonio; Mullol, Joaquim (2013-04-11). «Safety evaluation of desloratadine in allergic rhinitis». Expert Opinion on Drug Safety (Informa Healthcare) 12 (3): 445–453. doi:10.1517/14740338.2013.788148. ISSN 1474-0338. PMID 23574541.
«Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence». World Allergy Organ J 4 (2): 47–53. 2011. doi:10.1097/WOX.0b013e3182093e19. PMID 23268457.
Kazmi, F.; Yerino, P.; Barbara, J. E.; Parkinson, A. (2015-07-01). «Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor». Drug Metabolism and Disposition 43 (9): 1294–1302. doi:10.1124/dmd.115.065011. ISSN 1521-009X. PMID 26135009.
«Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice». BMJ 320 (7243): 1184–6. 2000. doi:10.1136/bmj.320.7243.1184. PMID 10784544. PMC 27362. http://bmj.bmjjournals.com/cgi/content/full/320/7243/1184.

pubmedcentral.nih.gov

«Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence». World Allergy Organ J 4 (2): 47–53. 2011. doi:10.1097/WOX.0b013e3182093e19. PMID 23268457.
«Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice». BMJ 320 (7243): 1184–6. 2000. doi:10.1136/bmj.320.7243.1184. PMID 10784544. PMC 27362. http://bmj.bmjjournals.com/cgi/content/full/320/7243/1184.

web.archive.org

See S (2003). «Desloratadine for allergic rhinitis». Am Fam Physician 68 (10): 2015–6. PMID 14655812. Αρχειοθετήθηκε από το πρωτότυπο στις 2005-07-24. https://web.archive.org/web/20050724082052/http://www.aafp.org/afp/20031115/steps.html. Ανακτήθηκε στις 2022-02-02.
«Aerius: EPAR – Product Information» (PDF). European Medicines Agency. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 5 Ιουλίου 2019. Ανακτήθηκε στις 21 Ιανουαρίου 2022.
«Aerius: EPAR – Scientific Discussion» (PDF). European Medicines Agency. 3 Απριλίου 2006. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2018. Ανακτήθηκε στις 2 Φεβρουαρίου 2022.

worldcat.org

González-Núñez, Vanesa; Valero, Antonio; Mullol, Joaquim (2013-04-11). «Safety evaluation of desloratadine in allergic rhinitis». Expert Opinion on Drug Safety (Informa Healthcare) 12 (3): 445–453. doi:10.1517/14740338.2013.788148. ISSN 1474-0338. PMID 23574541.
Kazmi, F.; Yerino, P.; Barbara, J. E.; Parkinson, A. (2015-07-01). «Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor». Drug Metabolism and Disposition 43 (9): 1294–1302. doi:10.1124/dmd.115.065011. ISSN 1521-009X. PMID 26135009.